For richer charts and full features, open SpikePanel on desktop.
Graded daily on value C-, growth C+, profitability B, momentum D, revisions C-. Sector-relative, identical for every user.
Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $CRS are available with SpikePanel Pro.
Key events, in time order
Net sales $798.2M vs $831M est., but EPS beat
Two independent sources flag Q1 report; aerospace demand and pricing may support, while medical weakness is a concern
$400M expansion boosts capacity, supporting $1.2-$1.3B FY29 operating income target
$0.20 per share dividend declared; Ken Giacobbe joins board, advancing governance and shareholder returns
Board authorizes new repurchase after prior program completion, signaling capital return commitment
Q4 EPS $3.23 beat, revenue beat, SAO margin record 37.8%
Call confirms strong aerospace demand, sets $1.2B-$1.3B FY2029 operating income target
None yet
None yet
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice